STTR Cancer

We're hiring! Come work on our team to help speed translational research across the Northwest region. We're looking for someone who is organized, good with people and has n understanding of the processes around human subjects and genomics research.

https://careers-fhcrc.icims.com/jobs/18202/san-coordinating-center-manager/job

Check out our website to learn more about our work:
https://research.fhcrc.org/specimen-acquisition-network/en.html

Specimen Acquisition Network (SAN) The Specimen Acquisition Network (SAN) is a network of Pacific Northwest human health-centered institutions supporting researcher access to biospecimens.

Congratulations to Dr. Alyssa Webster, the inaugural recipient of the Fred Hutch Brave Fellowship! Funds donated by Brooks Running on behalf of the Brave Like Gabe Foundation will support her work to identify new cures for leukemia:

New Brave Fellowship powers Dr. Alyssa Webster’s race for new leukemia cures Running helps Dr. Alyssa Webster to think through scientific challenges. Now, with her new Brave Fellowship, running is helping fuel her science by funding her research on leukemia.

As more COVID-19 vaccine trials are opening across the country, the Fred Hutch-based COVID-19 Prevention Network is working diligently to ensure there is diversity in the study populations. Read more about their efforts:

CoVPN team leads campaign to ensure diversity in COVID-19 vaccine trials Through the COVID-19 Prevention Network's operations center based at Fred Hutch, Dr. Larry Corey and the team are using the infrastructure of the Hutch-based HIV Vaccine Trials Network to drive conversations about diversity and inclusion in trials.

A new fellowship from the American Cancer Society will support Dr. Nithya Kartha's work in Dr. Sita Kugel's lab at Fred Hutch to identify vulnerabilities and targeted treatments for an aggressive pancreatic cancer sub-type. Learn more:

Seeking targeted treatments for pancreatic cancer Fred Hutch postdoc Dr. Nithya Kartha received a three-year fellowship from the American Cancer Society to discover potential targeted therapies for the most aggressive subtype of pancreatic cancer.